Global Renal Dialysis Market 2017-2021
About Renal Dialysis
Renal dialysis devices are the medical equipment used to artificially filter blood and remove excessive wastes such as drugs, urea, uric acid, creatinine, and poisons from the human body in patients with CKD. Dialysis enables diffusion of solute molecules through a semipermeable membrane from higher concentration to lower concentration. The semipermeable membrane prevents passage of larger molecules such as the colloidal plasma proteins and protoplasm. In addition, these devices maintain fluid, electrolyte, and acid-base balance in case of kidney damage or failure.
Technavio’s analysts forecast the global renal dialysis market to grow at a CAGR of 4.68% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global renal dialysis market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Renal Dialysis Market 2017-2021
Technavio recognizes the following companies as the key players in the global renal dialysis market: B. Braun Melsungen, Baxter, DaVita, Fresenius Medical Care, and NIPRO Medical.
Other Prominent Vendors in the market are: Asahi Kasei, BIOLIGHT, Diaverum, Huaren Pharmaceutical, Jihua Medical Apparatus & Instruments, Medical Components, Medtronic, NIKKISO, NxStage Medical, and SWS Hemodialysis Care.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is rising demand for home peritoneal dialysis treatment. Peritoneal dialysis treatment is increasingly being used to clean the waste fluid from the blood when the kidney fails to function. Such treatment utilizes catheter placement through the abdominal muscles, of which one end is put into the peritoneal space. The treatment process uses dialysate solution, which is left inside the peritoneal cavity.”
According to the report, one driver in the market is increasing number of ESRD patients. CKD is a medical condition that damages the kidney and results in it losing its ability to filter blood, leading to the accumulation of excess fluid waste that causes various health complications. Various risk factors associated with CKD are high blood pressure, heart diseases, obesity, and in some cases, it is hereditary. According to the CDC in 2017, approximately 30 million individuals have CKD, that means around 15% of the US adults have such diseases. However, not all the patients with kidney diseases progress to kidney failure. According to the CDC in 2014, around 118,000 individuals in the US started taking treatment for ESRD and 662,000 were living with a kidney transplant.
Further, the report states that one challenge in the market is high treatment costs. Patients with chronic cardiac diseases like ESRD require costly dialysis treatments, which even well-established economies find difficult to finance. The high cost of dialysis treatment, especially in low- and middle-income countries where the majority of the population is unaware of such treatment restrains the growth of the market. Government policies for insurance coverage and reimbursement for ESRD are different in different countries. Dialysis treatment consumes a lot of resources, as dialysis equipment and material are expensive. The costs incurred during treatment of renal failure using dialysis treatment are direct medical cost, direct non-medical cost, intangible cost, and indirect cost.
B. Braun Melsungen, Baxter, DaVita, Fresenius Medical Care, and NIPRO Medical, Asahi Kasei, BIOLIGHT, Diaverum, Huaren Pharmaceutical, Jihua Medical Apparatus & Instruments, Medical Components, Medtronic, NIKKISO, NxStage Medical, and SWS Hemodialysis Care.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook